2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$106.06+$2.27 (+2.18%)
Price as of Jul 14, 2026 4:21 AM EDT- $5.2BMarket Cap
- 654.84%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$106.06+$2.27 (+2.18%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $103.79 | ||
Change | -$3.79 (-3.52%) | ||
Open | $106.70 | ||
High | $108.78 | ||
Low | $100.63 | ||
Previous Close | $107.58 | ||
Volume | 1,258,573 | ||
30-Day Average Volume | 1,236,293 | ||
1-Week Change | -4.41% | ||
1-Month Change | 17.21% | ||
1-Year Change | 654.84% | ||
3-Year Change | 974.43% | ||
5-Year Change | 343.36% | ||
Fundamentals | |||
Shares Outstanding | 48.8M | ||
Total Assets | $410.2M | ||
Market Cap | $5.2B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.3M | ||
EBIT | $1.6M | ||
EBITDA | $1.6M | ||
Net Working Capital | $375.7M | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | 3,294 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -111 | ||
PEG | N/A | ||
Price/Free Cash Flow | -95 | ||
Price/Operating Cash Flow | -95 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue